Biologics License Application for Subcutaneous Formulation of "LEQEMBI®" for the Treatment of Early Alzheimer's Disease Accepted in China Life Science Investing
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference Medical Device Investing
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 Life Science Investing
